COVID-19 and cancer care: what do international guidelines say?

Tartarone, Alfredo; Lerose, Rosa

doi:10.1007/s12032-020-01406-5

Cited by 36 publications

(45 citation statements)

References 12 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 24 Some studies also found that patients with malignancy were especially vulnerable to COVID-19 because they generally had multiple risk factors for this infection, such as advanced age. 25 In the present study, we also found malignancy (OR 2.45; p =0.025) was independently associated with the hospitalization of the patients.…”

Section: Discussionsupporting

confidence: 72%

Risk factors for hospital admission among COVID-19 patients with diabetes

Hayek

Robert

Matar

et al. 2020

SMJ

View full text Add to dashboard Cite

‫العمر‬ ‫كان‬ ‫املنزل.‬ ‫في‬ ‫منهم‬ 52% ‫وعزل‬ ، ‫املستشفى‬ ‫إلى‬ ‫منهم‬ 48% ‫إدخال‬ ‫مت‬ ، ‫سنة‬ p=0.017(، 80 ‫؛‬ 2.56 ‫فردية]‬ ‫[نسبة‬ OR(‫سنة‬ 70-79 ‫بني‬ ‫األكبر‬ ‫مقارنة‬ ‫املستشفى‬ ‫إلى‬ ‫للدخول‬ ‫كبير‬ ‫بشكل‬ ‫عرضة‬ ‫أكثر‬)OR ‫؛84.6‬ p=0.001(9% ‫من‬ ‫أعلى‬ HbA1c ‫مستوى‬ ‫لديهم‬ ‫الذين‬ ‫املرضى‬ ، ‫وباملثل‬ ‫سنة.‬ 40< ‫ـ‬ ‫ب‬ ‫أمراض‬ ‫من‬ ‫يعانون‬ ‫الذين‬ ‫املرضى‬ ‫؛‬)OR ‫؛85.1‬ p=0.047(‫؛‬ 7%< ‫ـ‬ ‫ب‬ ‫مقارنة‬ ‫القلب‬ ‫أمراض‬ ،)OR ‫؛34.1‬ p=0.048(‫الدم‬ ‫ضغط‬ ‫ارتفاع‬ ‫مثل‬ ‫مصاحبة‬ ‫الدماغية‬ ‫الدموية‬ ‫األوعية‬ ‫أمراض‬ ،)OR ‫؛65.1‬ p=0.033(‫الدموية‬ ‫واألوعية‬ ‫كان‬ ،)OR ‫؛15.1‬ p=0.018(‫مزمن‬ ‫رئوي‬ ‫مرض‬ ،)OR ‫؛83.2‬ p=0.016(IIIa ، IIIb ،(‫املزمنة‬ ‫الكلى‬ ‫وأمراض‬ ،)OR ‫؛54.2‬ p=0.025(‫اخلبيث‬ ‫الورم‬ ‫عرضة‬ ‫أكثر‬)IV)OR ‫؛73.2‬ p=0.008(، CKD V)OR ‫؛70.5‬ p=0.007 OR(‫باألنسولني‬ ‫املعاجلني‬ ‫فإن‬ ، ‫وباملثل‬ ‫املستشفى.‬ ‫إلى‬ ‫للدخول‬ ‫ملحوظ‬ ‫بشكل‬ ‫غير‬ ‫باملرضى‬ ‫مقارنة‬ ‫املستشفى‬ ‫دخول‬ ‫لتطلب‬ ‫عرضة‬ ‫أكثر‬ ‫كانوا‬ ‫؛64.1)‬ p=0.03 ‫باألنسولني.‬ ‫املعاجلني‬ ‫تقدم‬ ‫أن‬ ‫وجد‬ ‫السكري،‬ ‫بداء‬ ‫املصابني‬ COVID-19 ‫مرضى‬ ‫بني‬ ‫اخلالصة:‬ ‫خطر‬ ‫عوامل‬ ‫أخرى‬ ‫مصاحبة‬ ‫أمراض‬ ‫ووجود‬ ،HbA1c ‫مستوى‬ ‫وارتفاع‬ ‫العمر،‬ ‫املستشفى‬ ‫لدخول‬ ‫كبيرة‬ Objectives: To elucidate the risk factors for hospital admission among COVID-19 patients with type 2 diabetes mellitus (T2DM).

show abstract

Section: Discussionsupporting

confidence: 72%

Risk factors for hospital admission among COVID-19 patients with diabetes

Hayek

Robert

Matar

et al. 2020

SMJ

View full text Add to dashboard Cite

show abstract

“…The most important point of the survey was to assess how the SARS-COV-2 pandemic would influence choice and decisions for treatment in NET patients. Risk assessments of treatments have been published by medical societies for other tumor entities [4]. Only recently, some general recommendations for NET patients have been published by an expert group [15].…”

Section: Discussionmentioning

confidence: 99%

“…Cancer patients are at high risk for a severe course of COVID-19 due to several factors such as immunosuppressed state, higher age and comorbidities (e.g., chronic lung disease, diabetes, cardiovascular diseases). Therefore, in the COVID-19 era, oncologists should carefully weigh risks/benefits when planning cancer therapies and follow-up appointments [4].…”

Section: Introductionmentioning

confidence: 99%

Professional Assessment of the Impact of COVID-19 on Handling NET Patients

Krug

Garbe

König

et al. 2020

JCM

View full text Add to dashboard Cite

The treatment and monitoring of patients with neuroendocrine tumors (NET) has been a major challenge during the COVID-19 pandemic. In a survey, we investigated the influence of COVID-19 on the care of NET patients in the German speaking countries Germany, Austria and Switzerland. The multidisciplinarity of all treating physicians in the outpatient and inpatient sector was reflected in our survey. Furthermore, we were able to present findings pertaining to the university and non-university medical care. Overall, only a minority of appointments were cancelled, mostly as a result of medical prioritization and less for fear of infection by patients. In the university sector, longer delays for diagnostic measures were observed in comparison to non-university care. During the COVID-19 crisis, NET patients rarely changed their current therapy, but the pandemic impacted the assessment of the different treatment modalities at risk of developing severe COVID-19 disease. This survey provides the first real-world data on the treatment of NET patients from the physicians’ perspective during the COVID-19 crisis. Despite delays in diagnostic procedures and outpatient appointments, only a minority of physicians foresee a major impact of COVID-19 on NET patient care.

show abstract

“…Bu pro-inflamatuvar sitokinlerin yüksek seviyede salınımı da sitokin fırtınasının gelişimine ve dolayısıyla akut solunum sıkıntısı sendromu (ARDS) ile ölüme neden olmaktadır (18). (46)(47).…”

Section: Koronavirüs Ailesi Ve Covid-19unclassified

Covid-19 ve Kanser Covid-19 and Cance

Karataş¹,

Tunçdemi̇r²

2018

TFK

View full text Add to dashboard Cite

Öz2019 Aralık ayında Çin'in Wuhan şehrinde ortaya çıkan ve koronavirüs ailesinin yeni üyesi olan SARS-CoV-2 kısa sürede tüm dünyaya yayılmış ve pandemi ilan edilmesine neden olmuş bir virüstür. Covid-19 olarak adlandırılan bu hastalık kronik rahatsızlığı bulunan ve yaşı 65 üzeri olan bireylerde ölüm riskini arttırmaktadır. Covid-19'un patogenezinde ölümü tetikleyen en ciddi mekanizmaların başında oluşturduğu sitokin fırtınası gelmektedir. Günümüzde hastalığa karşı aşı veya bu mekanizmaları düzenleyecek bir ilaç araştırmaları devam etse de ne yazık ki henüz net bir tedavi yöntemi bulunmamaktadır. Hızlı yayılması ve vaka sayılarındaki artış sağlık sektöründe büyük bir yoğunluğa neden olduğu için Covid-19 tanısı konmayan fakat kanser gibi ciddi rahatsızlıkları olan bireylerin enfekte olma riskini azaltmaya yönelik kılavuzlar yayınlanmıştır. Bu derlemede Covid-19'un kökenini, patolojisini, neden mortalitesinin belirli durumlarda yüksek olduğunun yanı sıra bu hastalığın kanser hastalarına olan etkisi, Covid-19 tanısı konulan kanser hastalarının tedavisindeki komplikasyonlar ve kanser tedavisinde kullanılan inhibitörlerin Covid-19 üzerine etkisini kapsayan tedavi biçimlerini içeren kılavuz ve çalışmalar tartışılacaktır.

show abstract

COVID-19 and cancer care: what do international guidelines say?

Cited by 36 publications

References 12 publications

Risk factors for hospital admission among COVID-19 patients with diabetes

Risk factors for hospital admission among COVID-19 patients with diabetes

Professional Assessment of the Impact of COVID-19 on Handling NET Patients

Covid-19 ve Kanser Covid-19 and Cance

Contact Info

Product

Resources

About